1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Thrombectomy Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Aspiration Thrombectomy Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Mechanical Thrombectomy Devices
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Ultrasonic Thrombectomy Devices
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Application
7.1 Cardiovascular
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Neurovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Peripheral Vascular
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Argon Medical Devices Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Boston Scientific Corporation
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Edwards Lifesciences Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Johnson & Johnson
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Medtronic Plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Penumbra Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Spectranetics Corporation (Koninklijke Philips N.V.)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Stryker Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Teleflex Incorporated
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Terumo Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
世界の血栓除去デバイス市場予測2023年-2028年 |
| 【英語タイトル】Thrombectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 | |
 | ・商品コード：IMARC23FE0154 ・発行会社（調査会社）：IMARC ・発行日：2023年2月1日 ・ページ数：198 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール ・調査対象地域：グローバル ・産業分野：医療機器 |
| Single User | USD2,999 ⇒換算￥455,848 | 見積依頼/購入/質問フォーム |
| Five User | USD3,999 ⇒換算￥607,848 | 見積依頼/購入/質問フォーム |
| Enterprisewide | USD4,999 ⇒換算￥759,848 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| IMARC社の調査レポートによると、世界の血栓除去デバイス市場規模は2022年13億ドルに達しました。今後、2028年には18億ドルまで拡大し、2023年から2028年の間に年平均5.4％で成長すると予測されます。本レポートでは、血栓除去デバイスの世界市場について調査・分析し、序論、範囲・手法、エグゼクティブサマリー、イントロダクション、製品種類別（吸引血栓除去装置、機械式血栓除去装置、超音波血栓除去装置、その他）分析、用途別（心臓血管、神経血管、末梢血管）分析、エンドユーザー別（病院＆クリニック、ASC、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況など、以下の構成でお届けします。なお、本書には、Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Cardinal Health Inc., Catalent Inc., Fresenius SE & Co. KGaA, Gerresheimer AG, Nipro Corporation, Schott AG, Terumo Corporation and West Pharmaceutical Services Inc.などの企業情報が含まれています。 ・序論 ・範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界の血栓除去デバイス市場規模：製品種類別 - 吸引血栓除去装置の市場規模 - 機械式血栓除去装置の市場規模 - 超音波血栓除去装置の市場規模 - その他製品の市場規模 ・世界の血栓除去デバイス市場規模：用途別 - 心臓血管用血栓除去デバイスの市場規模 - 神経血管用血栓除去デバイスの市場規模 - 末梢血管用血栓除去デバイスの市場規模 ・世界の血栓除去デバイス市場規模：エンドユーザー別 - 病院＆クリニックにおける市場規模 - ASCにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の血栓除去デバイス市場規模：地域別 - 北米の血栓除去デバイス市場規模 - アジア太平洋の血栓除去デバイス市場規模 - ヨーロッパの血栓除去デバイス市場規模 - 中南米の血栓除去デバイス市場規模 - 中東・アフリカの血栓除去デバイス市場規模 ・SWOT分析 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global thrombectomy devices market size reached US$ 1.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.
Thrombectomy devices offer numerous benefits in surrogate endpoints, such as biomarker analysis, infarct size reduction, ST-segment resolution and angiographic thrombolysis in myocardial infarction (TIMI) flow. These devices minimize blood loss and damage caused to the vessel wall during a procedure. Consequently, they find application in treating blood clots present in veins, arteries and capillaries. They are also used to treat pulmonary embolism and peripheral arterial diseases. At present, they are widely available in different sizes and diameters, depending on the affected area. Some of the most frequently used thrombectomy devices procedures are balloon embolectomy, surgical embolectomy and aspiration embolectomy.
Global Thrombectomy Devices Market Trends:
According to the World Health Organization (WHO), chronic diseases are the leading causes of death and disability around the world. Disease rates from these conditions are accelerating significantly on account of hectic schedules, sedentary lifestyles, rising consumption of fast food and the increasing number of individuals who smoke and consume alcohol. This represents one of the key factors propelling the growth of the thrombectomy devices market worldwide. Moreover, the growing geriatric population, along with the escalating demand for minimally invasive (MI) procedures and improving healthcare infrastructure in various countries, is also fueling the growth of the market. Furthermore, the leading manufacturers are increasing their investments in research and development (R&D) activities to introduce technologically advanced thrombectomy devices, which, in turn, is creating a positive outlook for the market. Besides this, favorable medical reimbursements and rising preference of these devices by surgeons for performing image-guided surgeries are anticipated to strengthen the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global thrombectomy devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application and end user.
Breakup by Product Type:
Aspiration Thrombectomy Devices
Mechanical Thrombectomy Devices
Ultrasonic Thrombectomy Devices
Others
Breakup by Application:
Cardiovascular
Neurovascular
Peripheral Vascular
Breakup by End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc, Penumbra Inc., Spectranetics Corporation (Koninklijke Philips N.V.), Stryker Corporation, Teleflex Incorporated and Terumo Corporation.
Key Questions Answered in This Report
1. What was the size of the global thrombectomy devices market in 2022?
2. What is the expected growth rate of the global thrombectomy devices market during 2023-2028?
3. What are the key factors driving the global thrombectomy devices market?
4. What has been the impact of COVID-19 on the global thrombectomy devices market?
5. What is the breakup of the global thrombectomy devices market based on the product type?
6. What is the breakup of the global thrombectomy devices market based on the application?
7. What is the breakup of the global thrombectomy devices market based on the end user?
8. What are the key regions in the global thrombectomy devices market?
9. Who are the key players/companies in the global thrombectomy devices market?
❖ レポートの目次 ❖
| ★調査レポート[世界の血栓除去デバイス市場予測2023年-2028年] (コード：IMARC23FE0154)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の血栓除去デバイス市場予測2023年-2028年]についてメールでお問い合わせ |
